Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of amlodipine + atorvastatin therapy in patients with concurrent hypertension and dyslipidaemia
2004-000354-22Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of amlodipine and atorvastatin in hypertension (HTN) and lipid disorder, sponsored by Pfizer. Primary endpoint: Primary efficacy endpoint. Started Jul 2004; status: completed.
02
Drugs
amlodipineatorvastatin
03
Conditions
hypertension (HTN)lipid disorder
Beyond the preview
Go deeper on 2004-000354-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000354-22.